Open original FDA record ↗Recall record
- FDA identifier
- Z-1391-2011
- Company in FDA record
- Haemonetics Corporation
- FDA classification date
- Feb 22, 2011
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 17, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
Update Instructions for Use for the CardioPAT® Manual for Leak Detection. User may mis-interpret the air-leak rate displayed by the cardioPAT device when making a determination about chest-drain removal, which could result in the patient experiencing a pneumothorax.
Source facts
- Action
- Haemonetics issued a Field Correction Notice on 1/25/11 . with the Air Leak Detection addendum and index be inserted into the appropriate document, applied to all cardioPAT@ devices on site. The serial number for each cardioPAT device on site should be recorded on the attached acknowledgement and the completed acknowledgement should be returned to your Haemonetics Sales Consultant. A Haemonetics Sales Consultant will train on the content of these items and insert them into the Operator Manuals
- Initiated
- 2011-01-25
- Root cause
- Labeling design
- Terminated
- 2013-01-14
- Distribution
- Worldwide distribution, including USA, Australia, Belgium, Canada, Switzerland, China, Germany, Finland, France, United Kingdom, Hong Kong, Israel, Italy, Japan, Netherlands, Russian Federation, and Sweden.
- Recall number
- Z-1391-2011
- Recall status
- Terminated
- CDRH record ID
- 97477
- FDA classified
- 2011-02-22
- Recall event number
- 57805